The story of the ERVEBO® vaccine highlights the power of science and collaboration. Wellcome remains committed to working with global partners, sharing knowledge and facilitating partnerships.
While this was a breakthrough for Ebola, this vaccine is only effective against the Zaire strain. There is still more research and innovation needed to protect vulnerable communities against other strains, like the 2025 outbreak caused by the Sudanvirus strain in Uganda.
Preparing for future outbreaks requires boosting vaccine infrastructures and cultivating global research cooperation. It also involves creating policy frameworks that can quickly address new health threats.
Wellcome is committed to supporting research and promoting strategies to effectively fight infectious diseases in the most affected communities.